8 Challenges in clinical application Considering the enumerated benefits of GLP-1RA compared to other glucose-lowering drugs including the reduction in HbA1c and weight reduction benefits alongside decreased risk for hypoglycaemia (122) it is not cost effective if used in combination with another incretin (107)
At Genova Diagnostics, our testing is designed to look beneath the number on the scale and into the systems that determine how well a patient will actually live on GLP1 therapy: Gut health and the microbiome: Stool profiles (including GI Effects and targeted assays such as Akkermansia assessment) help clinicians understand digestion, inflammation, dysbiosis, and key organisms linked with metabolic health and GLP1 signaling
Without intervention, approximately 15% to 30% of people with prediabetes will develop type 2 diabetes within five years
The diabetes medication Ozempic has been in the news ever since the FDA approved it for blood sugar control and obesity treatment
Months 2-3: Developing Automaticity During the second and third months, injection becomes routine
If youre considering either of these medications, its important to understand how they work and how they compare